Learn the Latest On Alcohol Research
The National Institute on Alcohol Abuse and Alcoholism is collaborating with APA on a special track of sessions at the 2006 annual meeting next month in Toronto. The track will feature symposia, workshops, forums, and lectures by some of the world's leading scientists. In addition to stressing the development of clinical knowledge and skills, these sessions will highlight important new findings in epidemiology, genetics, neuroscience, prevention, and treatment.
Monday, May 22
9 a.m.-10:30 a.m.
Issue Workshop 3
Managing Complex Comorbid Psychiatric and Alcohol Use Disorders in Psychiatric Practice
Toronto Convention Centre, North Level 200, Room 206 E/F
11 a.m.-12:30 p.m.
Research Consultation
Clinical Research on Alcohol Use Disorders
Intercontinental Hotel, Main Level, Oakville Room
Noon-1:30 p.m.
Forum 4
Women and Alcohol Use Disorders
Toronto Convention Centre, South Level 800, Room 801 B
2 p.m.-5 p.m.
Symposium 13
Substance Use Disorders in the U.S.
Toronto Convention Centre, South Level 700, Room 713 A/B
Prevalence and Correlates of Prescription Drugs Nonmedical Use and Use Disorders In the United States: 1991-1992 and 2001-2002
Alcohol and Drug Dependence and the Specificity of Family History
Prevalence, Correlates, and Comorbidity of DSM-IV Drug Use Disorders
Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
The Relationship of Family History to Cocaine and Cannabis First Use and Dependence
Symposium 26
Taking Science to Policy: Efforts to Reduce Harms Related to Alcohol Misuse
Royal York, Mezzanine Floor, Manitoba Room
The Magnitude and Prevention of Underage Drinking Problems
Pragmatic Science: The New NIAAA Clinician's Guide
Alcohol Interventions in Trauma Centers Reduce Reinjury Rates: State Laws and Insurance Regulations Prevent Their Implementation
Implementing Alcohol Treatment for People With Co-Occurring Disorders In Psychiatric Treatment Settings
What Kind of Treatment System Is Necessary to Implement Evidence-Based Practices?
Tuesday, May 23
9 a.m.-10:30 a.m.
Lecture 13
What Have We Learned About Alcoholism From Animal Models?
Toronto Convention Centre, South Level 700, Room 718 A/B
Ting-Kai Li, M.D., Director, National Institute on Alcohol Abuse and Alcoholism
Issue Workshop 40
Practical Pharmacotherapy for the Treatment of Alcohol Dependence
Toronto Convention Centre, South Level 700, Room 717 B
Noon- 1:30 p.m.
Forum 11
The Future of Alcohol Research: NIAAA Resident Travel Award Winners With Discussion by a Panel of Senior Researchers
Royal York, Mezzanine Floor, Territories Room
2 p.m.- 3:30 p.m.
Frontiers of Science Lecture 18
Pharmacogenetics of Alcohol: Are We There Yet?
Toronto Convention Centre, North Level 300, Exhibit Hall A Henry R. Kranzler, M.D.
Frontiers of Science Lecture 19
An Evidence-Based Clinician's Guide to the New Pharmacotherapies for Alcoholism
Toronto Convention Centre, South Level 700, Room 718 A/B Barbara J. Mason, Ph.D.
2 p.m.- 5 p.m.
Symposium 38
Screening, Diagnosis, and Management of Alcohol Use Disorders in Psychiatric Practice
Toronto Convention Centre, North Level 200, Room 206 E/F
Screening, Assessment, and Management Using the NIAAA Clinician's Guide
Motivational Enhancement Strategies to Address Substance Use Disorders
Integrating Pharmacotherapy for Alcohol Dependence Into General Psychiatric Practice
Meeting the Addiction Medicine Needs of Patients in a General Psychiatric Practice
Symposium 48
Substance Use Disorders: Planning a Research Agenda for DSM-V
Toronto Convention Centre, South Level 700, Room 716 A
Adolescents and Substance Related Disorders: Research Agenda to Guide Decisions on DSM-V
Methods for DSM-V Research Work Groups to Address Key Diagnostic Issues for Substance Use Disorders
Substance Use Disorder Comorbidity and DSM-V
What Can Human Brain Imaging Tell Us About Addiction?
Symposium 59
Genetic Findings Related to Alcohol Dependence and Related Conditions
Royal York, Mezzanine Floor, Quebec Room
Genetic Susceptibility for Alcohol Dependence: Recent Findings
At Risk Families: A Multigenerational Study of Alcoholism
Further Characterization of the Risk Associated With GABA-A Receptor Genes
Neurophysiological Endophenotypes and the Risk for Alcohol Dependence and Related Disorders
Prediction of Alcohol Problems Using a Prospective Longitudinal Design Including Genotype
Wednesday, May 24
9 a.m.-10:30 a.m.
Lecture 21
Combining Neuroimaging and Pharmacology To Better Treat Alcoholism?
Toronto Convention Centre, North Level 300, Exhibit Hall A Karl F. Mann, M.D.
9 a.m.-noon
Media Presentation Workshop 6
Carter's Addiction: Substance Use Disorders in Physicians
Royal York, Mezzanine Floor, Quebec Room
11 a.m.-12:30 p.m.
Lecture 24
A University President's Perspective on Alcohol Related Research
Toronto Convention Centre, North Level 300, Exhibit Hall A Rev. Edward Malloy, C.S.C., President Emeritus, University of Notre Dame
Lecture 25
Beyond Dopamine: Neuroadaptations, Negative Affect, and Clinically Relevant Treatment Targets in Alcoholism
Toronto Convention Centre, South Level 700, Room 718 A/B Markus Heilig, M.D.
11 a.m.- 12:30 p.m.
Issue Workshop 68
Applying for National Institute on Alcohol Abuse and Alcoholism Research Money: Some Things You Didn't Learn in Graduate School
Toronto Convention Centre, South Level 700, Room 709
2 p.m.-3:30 p.m.
Lecture 26
Medications That Act at Ion Channels as Treatment for Alcohol Dependence
Toronto Convention Centre, North Level 100, Room 105 Bankole A. Johnson, M.D., Ph.D.
2 p.m.-5 p.m.
Symposium 66
Risk Factors, Personality Variables, and Addictive Disorders
Toronto Convention Centre, North Level 100, Room 104 A
Risk Factors for Addictive Disorders
Dependency and Suicidality in Addictive Disorders
Depressive Psychopathology in Addictive Disorders
Sensation Seeking and Addictive Disorders
Addictive Disorder: Goodman's Concept of Addiction, A Study of 692 Addictive Subjects
Symposium 82
Adolescent Alcohol Use Disorders and Psychiatric Comorbidity
Toronto Convention Centre, South Level 700, Room 716 A
Trauma and Alcohol Use Disorders in Adolescents: Psychiatric Comorbidity and Adult Outcomes
Assessing Alcohol Problems in Adolescents With Psychiatric Comorbidity
Treatment of Adolescents With Alcohol Problems and Major Depression
When ADHD and Substance Use Disorders Collide
Symposium 87
Alcohol, Drugs, and Psychiatric Disorders in the U.S.
Toronto Convention Centre, South Level 800, Room 801 B
Comorbidity of Pain and Substance Use Disorders in the U.S.
Antisocial Personality Disorder and Lifetime Course of Alcohol Use Disorders in the U.S. General Population
Prevalence, Correlates, and Comorbidity of Alcohol Use Disorders in the U.S.
Prevalence, Correlates, and Comorbidity of Nonmedical Sedative, Tranquilizer, Opioid, and Amphetamine Use, Abuse, and Dependence in the U.S.
Cannabis Withdrawal Syndrome in 2,613 Lifetime Heavy Cannabis Users From a National Survey: Symptom Prevalence, Factor Structure, and Correlates
Symposium 88
Sobering Facts: Alcohol Dependence and Treatment Interventions
Toronto Convention Centre, South Level 800, Room 803 A/B
The Impact of Alcohol Use Disorders
Alcohol Dependence: Difficulties in Diagnosis
Integrating Pharmacotherapy and Psychosocial Support in Treating the Alcohol-Dependent Patient
Pharmacotherapy for the Treatment of Alcohol Dependence: Review of Outcome Data
Symposium 97
Translating the Neurobiology of Alcoholism Into Clinical Treatments
Royal York, Convention Floor, Ballroom
Lost in Translation: Preclinical Studies of Genetic Susceptibility and Neuroadaptations Point to a Growing List of Novel Candidate Targets for Treatment of Alcoholism
Medications for Treating Alcoholism: From Animal Models to Clinical Usefulness
Animal Models for Novel Medications for Alcoholism: View From the Dark Side
Alcohol Relapse-Like Behavior in Laboratory Animals: The Nociceptin/Orphanin Fq System: A Potential Target for the Development of New Pharmacotreatments
Development of a Human Laboratory Model of Risk Factors for Relapse in Alcohol Dependence, Implications for Predicting Medication Efficacy in Clinical Trials
Thursday, May 25
11 a.m.-12:30 p.m.
Issue Workshop 99
Disasters, Public Policy, and Addiction Psychiatry
Toronto Convention Centre, North Level 200, Room 206 C/D
Issue Workshop 102
Medical Comorbidity in Dual-Diagnosis Patients
Toronto Convention Centre, South Level 700, Room 705
Information & Authors
Information
Published In
History
Published online: 21 April 2006
Published in print: April 21, 2006
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
Get Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).